Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.
January 2026
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
February 2026
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 |
March 2026
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 | 31 |
Press releases published on February 18, 2026
Feb. 18, 2026
Theriva™ Biologics concede la licencia de SYN-020 a Rasayana Therapeutics para numerosas indicaciones
Indeterminate
GlobeNewswire
Feb. 18, 2026
Stoked Bio Secures Exclusive Global License to Develop a Promising New Therapy for Crohn’s Disease
Indeterminate
GlobeNewswire
Feb. 18, 2026
Vystar Announces 2-Week-Long Memorabilia Sweepstakes on X Platform
Indeterminate
GlobeNewswire
Feb. 18, 2026
MYOS PET Powers Pekingese Performance at 150th Westminster Kennel Club Dog Show
Indeterminate
GlobeNewswire
Feb. 18, 2026
Akari Therapeutics to Present at the 2026 Biocom Global Partnering & Investor Conference
Indeterminate
GlobeNewswire
Feb. 18, 2026
Imprivata Patient Access Now Available in Epic Toolbox for Identity Verification in MyChart
Indeterminate
GlobeNewswire
Feb. 18, 2026
MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Indeterminate
GlobeNewswire
Feb. 18, 2026
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
Indeterminate
GlobeNewswire
Feb. 18, 2026
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025
Indeterminate
GlobeNewswire
Feb. 18, 2026
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend
Indeterminate
GlobeNewswire
Feb. 18, 2026
GLP-1 Usage Increases 67% While Bariatric Surgeries Decline, but Long-Term Benefits Remain Unclear
Indeterminate
GlobeNewswire